Total Payments
$12,739
2024 Payments
$1,837
Companies
63
Transactions
879
Medicare Patients
92,346
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$12,605 (99.0%)
Education$133.59 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,605 | 874 | 99.0% |
| Education | $133.59 | 5 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,343 | 135 | $0 (2024) |
| ABBVIE INC. | $1,201 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $991.18 | 64 | $0 (2024) |
| Lilly USA, LLC | $897.41 | 66 | $0 (2024) |
| Astellas Pharma US Inc | $885.90 | 40 | $0 (2024) |
| Amgen Inc. | $727.83 | 45 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $560.19 | 36 | $0 (2024) |
| PFIZER INC. | $519.70 | 48 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $470.99 | 59 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $438.56 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,837 | 101 | AstraZeneca Pharmaceuticals LP ($213.62) |
| 2023 | $2,124 | 138 | ABBVIE INC. ($304.71) |
| 2022 | $1,897 | 131 | ABBVIE INC. ($314.87) |
| 2021 | $2,010 | 139 | AbbVie Inc. ($363.20) |
| 2020 | $1,181 | 88 | Novo Nordisk Inc ($218.02) |
| 2019 | $1,402 | 109 | Astellas Pharma US Inc ($212.34) |
| 2018 | $1,745 | 135 | AstraZeneca Pharmaceuticals LP ($240.98) |
| 2017 | $542.08 | 38 | Merck Sharp & Dohme Corporation ($88.46) |
All Payment Transactions
879 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Heart Failure | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: Obesity | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $68.11 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $34.38 | General |
| Category: UROLOGY | ||||||
| 09/16/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Diabetes | ||||||
| 09/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.76 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 31,749 | 50,386 | $2.0M | $699,876 |
| 2022 | 46 | 30,183 | 47,144 | $1.8M | $653,433 |
| 2021 | 40 | 28,462 | 42,354 | $1.6M | $582,275 |
| 2020 | 26 | 1,952 | 3,427 | $353,203 | $119,803 |
Total Patients
92,346
Total Services
143,311
Medicare Billing
$2.1M
Procedure Codes
156
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 397 | 1,128 | $385,526 | $88,601 | 23.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 3,885 | 6,528 | $208,113 | $85,584 | 41.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 3,589 | 5,182 | $207,228 | $85,215 | 41.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 1,811 | 2,501 | $176,220 | $72,518 | 41.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 3,810 | 6,776 | $136,536 | $56,120 | 41.1% |
| 80076 | Liver function blood test panel | Office | 2023 | 3,734 | 6,372 | $123,999 | $51,000 | 41.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 3,868 | 6,138 | $113,430 | $46,662 | 41.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 2,940 | 4,212 | $90,347 | $37,203 | 41.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 1,837 | 3,247 | $75,071 | $30,848 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 197 | 197 | $62,315 | $23,983 | 38.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 883 | 883 | $48,238 | $16,706 | 34.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 682 | 874 | $31,359 | $12,918 | 41.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 30 | 388 | $52,380 | $10,489 | 20.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 36 | 302 | $49,830 | $9,836 | 19.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 30 | 224 | $44,576 | $7,234 | 16.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 398 | 778 | $8,698 | $6,456 | 74.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 397 | 579 | $14,556 | $5,987 | 41.1% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2023 | 618 | 648 | $11,100 | $4,575 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 81 | $18,917 | $4,493 | 23.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 206 | 227 | $18,346 | $4,354 | 23.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 96 | $12,576 | $4,342 | 34.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 259 | 319 | $10,355 | $4,262 | 41.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 182 | 236 | $10,330 | $4,253 | 41.2% |
| 83550 | Iron binding capacity | Office | 2023 | 301 | 381 | $7,921 | $3,258 | 41.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 203 | 222 | $7,770 | $3,199 | 41.2% |
About Dr. Gregory Parker, MD
Dr. Gregory Parker, MD is a Family Medicine healthcare provider based in Columbus, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851392575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Parker, MD has received a total of $12,739 in payments from pharmaceutical and medical device companies, with $1,837 received in 2024. These payments were reported across 879 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($12,605).
As a Medicare-enrolled provider, Parker has provided services to 92,346 Medicare beneficiaries, totaling 143,311 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Columbus, GA
- Active Since 08/03/2005
- Last Updated 02/15/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1851392575
Products in Payments
- FARXIGA (Drug) $694.52
- VRAYLAR (Drug) $605.79
- Ozempic (Drug) $546.91
- MYRBETRIQ (Drug) $546.71
- Kerendia (Drug) $438.56
- XARELTO (Drug) $407.46
- JARDIANCE (Drug) $374.64
- ENTRESTO (Drug) $352.89
- UBRELVY (Drug) $270.54
- Vascepa (Drug) $269.70
- TRULICITY (Drug) $257.65
- Dayvigo (Drug) $250.53
- Saxenda (Drug) $244.57
- ELIQUIS (Drug) $233.40
- JANUVIA (Drug) $231.15
- NURTEC ODT (Drug) $227.44
- QULIPTA (Drug) $227.05
- MOUNJARO (Drug) $220.99
- Wegovy (Drug) $211.71
- Rybelsus (Drug) $200.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Columbus
Brian Beesley, Do, DO
Family Medicine — Payments: $1.5M
Family Medicine $1.5M
Dr. Jeffrey Kingsley, D.o, D.O
Family Medicine — Payments: $407,144
Family Medicine $407,144
Dr. Joseph Surber, Do, DO
Family Medicine — Payments: $147,174
Family Medicine $147,174
Bantwal Baliga, Md,Dgo, MD,DGO
Family Medicine — Payments: $124,562
Family Medicine $124,562
Bryan Feldman, D.o, D.O
Family Medicine — Payments: $48,287
Family Medicine $48,287
Elizabeth Martin, M.d, M.D
Family Medicine — Payments: $27,168
Family Medicine $27,168